Results 211 to 220 of about 105,036 (275)

Are pharmaceutical patents protected by human rights? [PDF]

J Med Ethics, 2008
Millum J.
europepmc   +1 more source

Tailoring the Properties of Functional Materials With N‐Oxides

Advanced Functional Materials, EarlyView.
The properties of materials bearing N‐oxide groups are often dominated by the polar N+─O− bond. It provides hydrophilicity, selective ion‐binding, electric conductivity, or antifouling properties. Many of the underlying mechanisms have only recently been discovered, and the interest in N‐oxide materials is rapidly growing.
Timo Friedrich, Michelle Kobus, Shirin Mesgarha, Erica Moretto, Laurens Grosche, Wolfgang Maison   +5 more
wiley   +1 more source

New Therapeutic Options for Fusariosis: A Patent Review (2008-2023). [PDF]

J Fungi (Basel)
Faccin ID, Salomé TM, de Almeida de Souza GH, da Costa Xavier L, Alves IA, Lima VCF, Lucini F, Simionatto S, Rossato L.   +8 more
europepmc   +1 more source

Building a Better Innovation System: Combining Facially Neutral Patent Standards withTherapeutics Regulation [PDF]

, 2008
Rai, Arti K.
core   +1 more source

Spatially Resolved Click Patterning of Dyes on Graphene for 2D Hybrids with Regiotunable Fluorescence

Advanced Functional Materials, EarlyView.
Well‐structured graphene hybrid architectures featuring spatially resolved fluorescent properties represent a promising but so‐far elusive synthetic target. A robust and straightforward method for fabricating well‐organized graphene‐dye hybrid nanoassemblies through a combination of reductive patterning and conventional click chemistry is presented ...
Sabrin Al‐Fogra, Bowen Yang, Boris Morozov, Filip Božinović, Elena A. Mack, Sijia Feng, Evgeny A. Kataev, Norbert Jux, Dirk M. Guldi, Heiko Weber, Frank Hauke, Andreas Hirsch, Tao Wei   +12 more
wiley   +1 more source

Monoclonal antibody formulations: a quantitative analysis of marketed products and patents. [PDF]

MAbs
Peng Y, Lyu L, Chen S, Ning B, Li C, Wu CY, Hu Y.   +6 more
europepmc   +1 more source

Upconversion Nanoparticles Embedded Photonic Contact Lens for Transepithelial Corneal Crosslinking Using Hyaluronate – Riboflavin Conjugate

Advanced Functional Materials, EarlyView.
A minimally invasive, transepithelial corneal cross‐linking (TE‐CXL) approach is presented using upconversion nanoparticles (UCNPs)‐loaded contact lenses (UCLs), after topical delivery of hyaluronate–riboflavin conjugates. The NIR‐to‐UV/blue light conversion by UCNPs in a UCL can activate riboflavin for TE‐CXL, resulting in the biomechanical strength ...
Gibum Lee, Inhoo Choi, Anara Molkenova, Yengwoo Son, Seungmin Yang, Mina Kwon, Tae‐Im Kim, Ki Su Kim, Sei Kwang Hahn   +8 more
wiley   +1 more source

Quantifying Innovation in Stroke: Large Language Model Bibliometric Analysis.

J Med Internet Res
Marcus A, Lockwood-Taylor G, Rueckert D, Bentley P.   +3 more
europepmc   +1 more source

Prospects of nanotechnology and natural products for cancer and immunotherapy. [PDF]

Beilstein J Nanotechnol
Santos JFA, Brasileiro MB, Barreto PDC, Rocha LA, Júnior JACN.   +4 more
europepmc   +1 more source

Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy

Advanced Functional Materials, EarlyView.
A bimetallic Mn–Ca nanoreactor (MCC) is developed as a non‐nucleotide STING nanoagonist for cancer metalloimmunotherapy. MCC induces Ca2+ overload and hydroxyl radical generation, resulting in mitochondrial damage and mtDNA release. The released mtDNA cooperates with Mn2+ to robustly activate cGAS–STING signaling.
Xin Wang Mo, Nguyen Thi Nguyen, LiLi Guo, Ngoc Man Phan, Hyunsu Shin, Tae‐il Kim, Yu Seok Youn, Jaeyun Kim   +7 more
wiley   +1 more source